PaccMann^RL: Designing Anticancer Drugs with Reinforcement Learning w/ Jannis Born - #341
2020-01-23 · 42 min · episode 341 · 13 entities
Asserted relationships
-
→ appeared on The TWIML AI Podcast (formerly This Week in Machine Learning & Artificial Intelligence podcast0.68
evidence rules-v4
PaccMann^RL: Designing Anticancer Drugs with Reinforcement Learning w/ Jannis Born - #341
-
0.55
evidence rules-v4
Feed author/publisher: Sam Charrington
-
0.40
evidence rules-v4
Feed category: Science
-
0.40
evidence rules-v4
Feed category: Technology
-
0.40
evidence rules-v4
Feed category: News
-
0.40
evidence rules-v4
Feed category: Tech News
-
0.40
evidence rules-v4
Feed author/publisher: TWIML
Entities found in this episode
concepts 5
-
0.50
evidence rules-v4
Feed category: Science
-
0.50
evidence rules-v4
Feed category: Tech News
-
0.40
evidence rules-v4
Feed category: Science
-
0.40
evidence rules-v4
Feed category: News
-
0.40
evidence rules-v4
Feed category: Tech News
companys 4
-
0.70
evidence rules-v4
Feed author/publisher: TWIML
-
0.50
evidence rules-v4
Feed category: Technology
-
0.40
evidence rules-v4
Feed category: Technology
-
0.40
evidence rules-v4
Feed author/publisher: TWIML
persons 3
-
0.72
evidence rules-v4
PaccMann^RL: Designing Anticancer Drugs with Reinforcement Learning w/ Jannis Born - #341
-
0.70
evidence rules-v4
Feed author/publisher: Sam Charrington
-
0.55
evidence rules-v4
Feed author/publisher: Sam Charrington
podcasts 1
-
appeared on The TWIML AI Podcast (formerly This Week in Machine Learning & Artificial Intelligence podcast0.68
evidence rules-v4
PaccMann^RL: Designing Anticancer Drugs with Reinforcement Learning w/ Jannis Born - #341
Episode description as stored
Today we’re joined by Jannis Born, Ph.D. student at ETH & IBM Research Zurich, to discuss his “PaccMann^RL” research. Jannis details how his background in computational neuroscience applies to this research, how RL fits into the goal of anticancer drug discovery, the effect DL has had on his research, and of course, a step-by-step walkthrough of how the framework works to predict the sensitivity of cancer drugs on a cell and then discover new anticancer drugs.